Literature DB >> 21653741

Disturbed homeostasis and multiple signaling defects in the peripheral blood B-cell compartment of patients with severe chronic sarcoidosis.

Nam-Sihk Lee1, Laura Barber, Shaw M Akula, George Sigounas, Yash P Kataria, Sergio Arce.   

Abstract

The presence of hypergammaglobulinemia, autoantibodies, and circulating immune complexes suggests that humoral immunity may contribute to the pathogenesis of sarcoidosis. However, little is known about the role played by B cells in the development of this disease. Here we investigated the subpopulation distribution, response to stimulation, and levels of the nuclear transcription factor NF-κB/p65 in peripheral blood B cells from patients with severe chronic sarcoidosis. Patients with severe chronic sarcoidosis had absolute B-cell lymphopenia and exhibited significantly decreased frequencies and total numbers of memory (CD19(+) CD27(+)) B cells. The reduced numbers of memory B cells in these patients reflected a decrease in the total numbers of class-switched (CD19(+) CD27(+) IgD(-)) and unswitched (CD19(+) CD27(+) IgD(+)) memory B cells and coincided with an increased frequency of circulating (CD19(+/-) CD20(-) CD27(++)) plasmablasts. Polyclonal stimulation of sarcoid B cells resulted in reduced expression of activation markers (i.e., CD25, CD69, and CD86), decreased proliferation, and impaired plasma cell differentiation. Baseline expression of p65 in B cells was reduced in 65% of the patients. These results suggest disturbed homeostasis, intrinsic signaling defects, and anergy within the peripheral B-cell compartments of patients with severe chronic sarcoidosis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21653741      PMCID: PMC3147362          DOI: 10.1128/CVI.05118-11

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  67 in total

Review 1.  B cell inhibitory receptors and autoimmunity.

Authors:  Nicholas R Pritchard; Kenneth G C Smith
Journal:  Immunology       Date:  2003-03       Impact factor: 7.397

2.  Maintenance of serological memory by polyclonal activation of human memory B cells.

Authors:  Nadia L Bernasconi; Elisabetta Traggiai; Antonio Lanzavecchia
Journal:  Science       Date:  2002-12-13       Impact factor: 47.728

3.  Intrinsic differences in the proliferation of naive and memory human B cells as a mechanism for enhanced secondary immune responses.

Authors:  Stuart G Tangye; Danielle T Avery; Elissa K Deenick; Philip D Hodgkin
Journal:  J Immunol       Date:  2003-01-15       Impact factor: 5.422

Review 4.  Genetic basis of remitting sarcoidosis: triumph of the trimolecular complex?

Authors:  David R Moller; Edward S Chen
Journal:  Am J Respir Cell Mol Biol       Date:  2002-10       Impact factor: 6.914

5.  The etiologic agent of sarcoidosis: what if there isn't one?

Authors:  Marc A Judson
Journal:  Chest       Date:  2003-07       Impact factor: 9.410

6.  B cells in the aged: CD27, CD5, and CD40 expression.

Authors:  Giuseppina Colonna-Romano; Matteo Bulati; Alessandra Aquino; Giuseppe Scialabba; Giuseppina Candore; Domenico Lio; Massimo Motta; Mariano Malaguarnera; Calogero Caruso
Journal:  Mech Ageing Dev       Date:  2003-04       Impact factor: 5.432

7.  Mouse CD20 expression and function.

Authors:  Junji Uchida; Youngkyun Lee; Minoru Hasegawa; Yinghua Liang; Alice Bradney; Julie A Oliver; Kristina Bowen; Douglas A Steeber; Karen M Haas; Jonathan C Poe; Thomas F Tedder
Journal:  Int Immunol       Date:  2004-01       Impact factor: 4.823

Review 8.  Sarcoidosis or Sjögren syndrome? Clues to defining mimicry or coexistence in 59 cases.

Authors:  Manuel Ramos-Casals; Pilar Brito-Zerón; Mario García-Carrasco; Josep Font
Journal:  Medicine (Baltimore)       Date:  2004-03       Impact factor: 1.889

Review 9.  Disturbances in peripheral blood B cell subpopulations in autoimmune patients.

Authors:  K N Potter; C I Mockridge; A Rahman; S Buchan; T Hamblin; B Davidson; D A Isenberg; F K Stevenson
Journal:  Lupus       Date:  2002       Impact factor: 2.911

Review 10.  Genetic aspects of Sjögren's syndrome.

Authors:  Anne I Bolstad; Roland Jonsson
Journal:  Arthritis Res       Date:  2002-09-24
View more
  24 in total

1.  Solving the Conundrum: Immunogenetics of Sarcoidosis.

Authors:  Naftali Kaminski; Wonder P Drake
Journal:  Am J Respir Crit Care Med       Date:  2015-09-15       Impact factor: 21.405

Review 2.  Potential immunotherapies for sarcoidosis.

Authors:  Van Le; Elliott D Crouser
Journal:  Expert Opin Biol Ther       Date:  2018-01-17       Impact factor: 4.388

3.  Rituximab in the treatment of refractory pulmonary sarcoidosis.

Authors:  Nadera J Sweiss; Elyse E Lower; Mehdi Mirsaeidi; Steven Dudek; Joe G N Garcia; David Perkins; Patricia W Finn; Robert P Baughman
Journal:  Eur Respir J       Date:  2014-01-31       Impact factor: 16.671

Review 4.  Targeting CD4(+) T cells for the treatment of sarcoidosis: a promising strategy?

Authors:  Lindsay J Celada; Wonder P Drake
Journal:  Immunotherapy       Date:  2015       Impact factor: 4.196

Review 5.  The Evolving Landscape of Cutaneous Sarcoidosis: Pathogenic Insight, Clinical Challenges, and New Frontiers in Therapy.

Authors:  Julie H Wu; Sotonye Imadojemu; Avrom S Caplan
Journal:  Am J Clin Dermatol       Date:  2022-05-18       Impact factor: 6.233

6.  Association of serum TNF-α, IL-8 and free light chain with HLA-DR B alleles expression in pulmonary and extra-pulmonary sarcoidosis.

Authors:  Esmaeil Mortaz; Hale Abdoli Sereshki; Atefeh Abedini; Arda Kiani; Mehdi Mirsaeidi; Dina Soroush; Johan Garssen; Aliakbar Velayati; Frank A Redegeld; Ian M Adcock
Journal:  J Inflamm (Lond)       Date:  2015-03-19       Impact factor: 4.981

7.  B-cell subpopulations in children: National reference values.

Authors:  Marie Duchamp; Delphine Sterlin; Aminata Diabate; Béatrice Uring-Lambert; Valérie Guérin-El Khourouj; Brigitte Le Mauff; Delphine Monnier; Christophe Malcus; Myriam Labalette; Capucine Picard
Journal:  Immun Inflamm Dis       Date:  2014-07-31

8.  Active chronic sarcoidosis is characterized by increased transitional blood B cells, increased IL-10-producing regulatory B cells and high BAFF levels.

Authors:  Anne Saussine; Abdellatif Tazi; Séverine Feuillet; Michel Rybojad; Caroline Juillard; Anne Bergeron; Valérie Dessirier; Fatiha Bouhidel; Anne Janin; Armand Bensussan; Martine Bagot; Jean-David Bouaziz
Journal:  PLoS One       Date:  2012-08-22       Impact factor: 3.240

9.  Rituximab in refractory sarcoidosis: a single centre experience.

Authors:  Francesco Cinetto; Nicolò Compagno; Riccardo Scarpa; Giacomo Malipiero; Carlo Agostini
Journal:  Clin Mol Allergy       Date:  2015-09-01

10.  Effects of infliximab on lung and circulating natural killer cells, CD56+ T cells and B cells in sarcoidosis.

Authors:  Susanna Kullberg; Natalia V Rivera; Johan Grunewald; Anders Eklund
Journal:  BMJ Open Respir Res       Date:  2021-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.